Trials / Completed

CompletedNCT00002057

Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC

Status: Completed
Phase: N/A
Study type: Interventional
Enrollment: —

Sponsor: Bristol-Myers Squibb · Industry
Sex: All
Age: 12 Years
Healthy volunteers: Not accepted

Summary

To determine a safe, effective, and convenient dosing schedule for nystatin pastilles in the prevention of oral candidiasis in patients with AIDS or AIDS related complex (ARC) (group III or IV, CDC classification).

Conditions

Candidiasis, Oral
HIV Infections

Interventions

Type	Name	Description
DRUG	Nystatin

Timeline

First posted: 2001-08-31
Last updated: 2007-10-02

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00002057. Inclusion in this directory is not an endorsement.